{{Short description|American professor}} '''Howard I. Scher''' is the Chief of the Genitourinary Oncology at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. He has a depth of experience in clinical trials for novel types of cancer treatment.<ref>{{cite interview|url=https://www.medscape.org/viewarticle/524950|first=Howard I.|last=Scher|title=Chemotherapy for Advanced Prostate Cancer: An Expert Interview With Dr. Howard I. Scher|website=Medscape|date=2006|accessdate=3 December 2016}}</ref>
== Early life and education == Scher earned his BS from Bates College and his MD from New York University School of Medicine before doing his residency at Bellevue Hospital.<ref>{{cite web|url=https://www.bloomberg.com/research/stocks/private/person.asp?personId=23065775&privcapId=3533888|title=Howard I. Scher M.D.: Executive Profile & Biography - Bloomberg|website=Bloomberg News |publisher=|accessdate=3 December 2016}}</ref> He married Deborah Ann Lafer in 1989.<ref>{{cite web|url=https://www.nytimes.com/1989/01/01/style/deborah-lafer-to-wed-dr-howard-i-scher.html|title=Deborah Lafer to Wed Dr. Howard I. Scher|date=1 January 1989|work=The New York Times|accessdate=3 December 2016}}</ref>
== Career == Scher has been an investigator at Memorial Sloan Kettering Cancer Center since 1992 and Professor of Medicine at the Weill Cornell Medical College.<ref>{{cite web|url=https://www.mskcc.org/cancer-care/doctors/howard-scher|title=Howard I. Scher - Memorial Sloan Kettering Cancer Center|publisher=|accessdate=3 December 2016}}</ref> His areas of research include PI3K, the androgen receptor, HSP90, and immunotherapy.
Scher is on the board of directors at Asterias, a biotechnology company.<ref>{{cite web|url=http://asteriasbiotherapeutics.com/howard-i-scher-m-d-leading-clinical-oncology-expert-joins-the-board-of-directors-of-asterias-biotherapeutics/|title=Howard I. Scher M.D., Leading Clinical Oncology Expert, Joins the Board of Directors of Asterias Biotherapeutics|publisher=|accessdate=3 December 2016|archive-date=3 December 2016|archive-url=https://web.archive.org/web/20161203064852/http://asteriasbiotherapeutics.com/howard-i-scher-m-d-leading-clinical-oncology-expert-joins-the-board-of-directors-of-asterias-biotherapeutics/|url-status=dead}}</ref>
Scher was awarded American Association for Cancer Research's 2015 Team Science Award along with Michael E. Jung and Charles Sawyers for their work in the development of enzalutamide.<ref>{{cite web|url=https://www.ascopost.com/issues/april-25-2015/michael-e-jung-phd-charles-sawyers-md-and-howard-i-scher-md-receive-team-science-award-from-american-association-for-cancer-research/|title=Michael E. Jung, PhD, Charles Sawyers, MD, and Howard I. Scher, MD, Receive Team Science Award From American Association for Cancer Research - The ASCO Post|publisher=|accessdate=3 December 2016}}</ref> He has also collaborated with Brett Carver and Neal Rosen, both also at MSKCC, on experimental cancer therapeutics for androgen-resistance prostate cancer.<ref>{{cite web|url=https://www.pcf.org/researcher/howard-scher/|title=Howard Scher, MD - Prostate Cancer Foundation|publisher=|accessdate=3 December 2016}}</ref>
Scher has published over 500 scholarly works.
== References == {{reflist}}
{{Authority control}}
{{DEFAULTSORT:Scher, Howard}} Category:Year of birth missing (living people) Category:Living people Category:American oncologists Category:Bates College alumni Category:New York University Grossman School of Medicine alumni